In this blog for people with Raynaud’s phenomenon, Dr Kevin Su, a Rheumatologist from Australia, looks at the latest Cochrane evidence on vasodilator drugs for Primary Raynaud’s phenomenon. Katie LeBlanc, a patient advocate, reflects on her experiences.